This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AboutAboutPathogen CoveragePatient Risk FactorsAntimicrobial Subscription Model PilotDosingDosingDosingPreparation GuideShelf Life and StorageEfficacy & SafetyEfficacy & SafetyMechanism of ActionREPROVE Phase III trial(HAP/VAP)RECLAIM Phase III trial(cIAI)RECAPTURE Phase III trial(cUTI)REPRISE Phase III trial(cIAI and cUTI)Safety and TolerabilityEfficacy and Safety Data for Paediatric PatientsSupport & ResourcesSupport & ResourcesAMS ResourcesSepsisWebinars (Live and On-demand)KOL Videos - ZaviceftaKOL Videos - Gram-negativeKOL Videos - Clinical experienceVideosMaterials

Information on how to access prescribing information and adverse event reporting can be found towards the bottom of the page.

Webinars

Explore our recorded webinars' library to listen to UK and international experts present their clinical experience on management of critically ill patients with MDR Gram-negative infections.

Professor Matteo Bassetti and  Philippe Montravers

Matteo Bassetti, Professor of Infectious Diseases, University of Genoa and Philippe Montravers, Head of the Department of Anaesthesia and Critical Care Medicine Unit, at Assistance Publique Hospitaux Paris, present risk stratification in infectious diseases and its role in achieving a truly patient-centric approach.

Luke Moore

Dr Luke Moore, Infectious Diseases Consultant at Chelsea and Westminster, presents the importance of risk stratification and screening for resistant Gram-negative infections.

Louise Sweeney

Dr Louise Sweeney, Consultant Clinical Microbiologist, presents the management of difficult-to-treat bacterial infections, resistance patterns including her experience on managing resistance in Manchester.

Andy Dodgson

Dr Andrew Dodgson, Consultant Microbiologist at Manchester, presents his perspective on early effective intervention in critically ill patients with MDR Gram-negative infections.

Access other case studies & videos

Abbreviations:

cUTI, complicated urinary tract infection, cIAI, complicated intra-abdominal infection; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia; MDR, multi-drug resistant; AMR, Antimicrobial Resistance; AMS, Antimicrobial Stewardship

Prescribing information​​​​​​​

Click here for Zavicefta® (ceftazidime avibactam) Prescribing Information

Click here for Cresemba® (isavuconazole) Prescribing Informatio

Click here for Zinforo® (ceftaroline fosamil) Prescribing Information

Click here for Meronem® (meropenem trihydrate) Prescribing Information

Click here for Tazocin® (piperacillin sodium, tazobactam sodium) Prescribing Information

Click here for Tygacil® (tigecycline) Prescribing Information in Great Britain
Click here for Tygacil® (tigecycline) Prescribing Information in Northern Ireland

Click here for Amikacin (amikacin sulfate)  Prescribing Information

Click here for Zyvox® (linezolid) Prescribing Information

Click here for Dalacin® (clindamycin hydrochloride) Prescribing Information

Click here for Zithromax® (azithromycin dihydrate) Prescribing Information

Click here for Tobramycin (tobramycin) Prescribing Information

PP-ZVA-GBR-1754. April 2023
Join us!

Follow the link to learn about out upcoming meetings and online webinars event - dates, location and agendas.

Register here Loading
Access results of ZAVICEFTA Phase III clinical trials in adult patients with cUTI, cIAI or HAP/VAP Learn more about the tolerability data of ZAVICEFTA from four Phase III clinical trials. View safety profile Loading

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2023 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7284. November 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​